Excipients choice justification for the creation of Adamantane-1ammonium 2-((5-(adamantane-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate tablets by the method of wet granulation (part 2)
DOI:
https://doi.org/10.14739/2409-2932.2017.2.103758Keywords:
adamantine, 1, 2, 4-triazole, tablets, excipients, wet granulation, neurolepticsAbstract
Introduction. The compound adamantane-1-ammonium 2-((5-(adamantane-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate was first synthesized at the Department of Toxicology and Inorganic Chemistry (Zaporizhya State Medical University), and received the name “Adatryn”. According to pharmacological studies, it shows neuroleptic properties and can be used in pill form, as most neuroleptics. Thus it is important to develop pills technology of adamantane-1-ammonium 2-((5-(adamantane-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate. During pharmacological studies the optimum dose at one time was 70 mg.
The aim of this work was to study the effect of different groups of excipients on pharmaco-technological properties of adamantane-1-ammonium 2-((5-(adamantane-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl) thio) acetate tablets.
Materials and methods. In the process, we studied four groups of adjuvants, which have various physical and technological properties. In the study of four qualitative factors we used one of dispersion analysis plans – four-factor experiment based on hyper-Greco-Latin square. 16 Excipients were studied, most of which have appeared on the market in recent years and there is no information about their use in pharmaceutical technology in creation of tablet dosage forms. In the experiments we used modern equipment to determine the mass uniformity of drugs, abrasion (abrasion device to determine Pharmatest D-63512 Hainburg, Germany), the time of disintegration (ERWEKA D-63150, Germany), and drugpres (Belorussia).
Results and discussion. Given pharmaco-technological properties and the results of morphometric studies proposed a method of wet granulation to obtain adamantan-1-ammonium 2-((5-(adamantan-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate tablets.
Conclusions. The influence of four groups of auxiliary substances on the technological characteristics of the adamantan-1-ammonium 2-((5-(adamantan-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetadote tablets, has confirmed the possibility of their obtaining by method of direct pressing. Optimal excipients and the composition of the drugs have been chosen.
References
(2008) Psyhіchne zdorovia naselennia Ukrainy : іnformacіino-analіtychnyi ogliad za 1990–2007 rr. [Mental health of the population of Ukraine: information-analytical review 1990-2007]. Kyiv: MOZ Ukrainy. [in Ukrainian].
Knysh, Ye. H., Panasenko, O. І., Odyntsova, V. M. & Safonov, A. A. (patentee) (2017) Patent Ukrainy 113484 Ukraina, MPK C07D 249/00, A61K 31/00 Adamantan-1-amonіiu 2-((5-(adamantan-1-іl)-4-fenіl-4N-1,2,4-triazol-3-іl)tіo)acetat, yakyi proiavliaie neiroleptychnu aktyvnіst' [Adamantan-1-ammonium 2-((5-(adamantan-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate that exhibits the neuroleptics activity]. Biuleten, 2. [in Ukrainian].
Knysh, Ye. H., Panasenko, O. І., Odyntsova, V. M. & Safonov, A. A. (patentee) (2017) Patent Ukrainy 113483 Ukraina, MPK C07D 249/00, A61K 31/00 Adamantan-1-amonіiu 2-((5-(adamantan-1-іl)-4-fenіl-4N-1,2,4-triazol-3-іl)tіo)acetat, yakyi proiavliaie zharoznyzhuiuchu aktivnіst' [Adamantan-1-ammonium 2-((5-(adamantan-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate that exhibits the antipyretic activity]. Biuleten, 2. [in Ukrainian].
Odyntsova, V. M. & Bidnenko, O. S. (2017). Pidbir dopomizhnykh rechovyn z metoiu stvorennia tabletok adamantan-1-amoniiu 2-((5-(аdamantan-1-іl)-4-fenil-4Н-1,2,4-triazol-3-іl)tіо)аtsetat metodom volohoi hranuliatsii [Selection of excipients to create tablets of adamantane-1-ammonium 2-((5-(adamantane-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate by the method of wet granulation. Part 1]. ScienceRise: Pharmaceutical Science, 1(5), 49–53. [in Ukrainian]. doi: 10.15587/2519-4852.2017.93722.
Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv» (2016) Derzhavna Farmakopeia Ukrainy [The state pharmacopeia of Ukraine]. (Vol. 1–3). Kharkiv [in Ukrainian].
Kovalenko, V. N. (Eds) (2017) Kompendium 2017 - lekarstvennye preparaty [Drugs]. Kyiv: MORION. [in Russian].
Hroshovy, T. A., Martseniuk, V. P., Kucherenko, L. І., et al. (2008) Matematychne planuvannia eksperymentu pry provedennі naukovyh doslіdzhen' v farmatsіi [Mathematical experiment planning at research in pharmacy]. Ternopіl: Ukrmedknyha. [in Ukrainian].
Hroshovy, T. A., Beley, N. M., Kucherenko, L. I., Vasenda, M. M., Markiv, N. V., Tryhubchak, O. V., & Paraschak, N. O. (2007) Optymіzatsіia tekhnolohіchnykh protsesіv stvorennia lіkarskhykh zasobіv za dopomohoiu matematychnoho planuvannia eksperymentu [Optimization of technological processes of drugs creation by means of mathematical planning of experiment]. Farmatsevtychnyi chasopys, 1(4), 21–29. [in Ukrainian]. doi: http://dx.doi.org/10.11603/2312-0967.2007.1.3107.
Kucherenko, L. I., Khromylyova, O. V., Moryak, Z. B., Tkachenko, G. I., & Vashchenko, E. V. 2014) Shсhodo postadіinoho kontroliu vyrobnytstva tabletok [Stage control of tablets manufacturing]. Current issues in pharmacy and medicine: science and practice, 2, 31–34. [in Ukrainian]. doi: http://dx.doi.org/10.14739/2409-2932.2014.2.26134.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
